Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine

Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials

(2020) Yanbo Yang et al.   JOURNAL OF HEADACHE AND PAIN

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

(2019) Simona Sacco et al.   JOURNAL OF HEADACHE AND PAIN

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination

(2019) Bianca Raffaelli et al.   JOURNAL OF HEADACHE AND PAIN

Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

(2019) Stephen D. Silberstein et al.   JOURNAL OF HEADACHE AND PAIN

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

(2018) Vladimir Skljarevski et al.   CEPHALALGIA

Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs

(2018) Jonathan Jia Yuan Ong et al.   DRUGS

Migraine is first cause of disability in under 50s: will health politicians now take notice?

(2018) Timothy J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Evaluation of Galcanezumab for the Prevention of Episodic Migraine

(2018) Virginia L. Stauffer et al.   JAMA Neurology

Galcanezumab: First Global Approval

(2018) Yvette N. Lamb   DRUGS

Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies

(2018) Stefanie Förderreuther et al.   JOURNAL OF HEADACHE AND PAIN

Galcanezumab in chronic migraine

(2018) Holland C. Detke et al.   NEUROLOGY

Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants

(2017) Yohannes W. Woldeamanuel et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Sex differences in the epidemiology, clinical features, and pathophysiology of migraine

(2017) Kjersti Grøtta Vetvik et al.   LANCET NEUROLOGY

Anti-CGRP monoclonal antibodies in migraine: current perspectives

(2016) Maria Adele Giamberardino et al.   Internal and Emergency Medicine

Epidemiology of Headache Disorders in the Asia-Pacific Region

(2014) Kuan-Po Peng et al.   HEADACHE

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)

(2013) Andrew M. Blumenfeld et al.   HEADACHE

Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan

(2012) Shuu-Jiun Wang et al.   CEPHALALGIA

Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan

(2012) Yong-Chen Chen et al.   JOURNAL OF HEADACHE AND PAIN

Adherence with Migraine Prophylaxis in Clinical Practice

(2012) Ariel Berger et al.   Pain Practice

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology

Migraine Disability Awareness Campaign in Asia: Migraine Assessment for Prophylaxis

(2008) Shuu-Jiun Wang et al.   HEADACHE

Impact of Migraine on the Employed Labor Force in Taiwan

(2008) Jong-Ling Fuh et al.   Journal of the Chinese Medical Association